| Chronic Myeloid Leukemia, BCR-ABL1 Positive predicts response to …PREDICTS_RESPONSE_TO199 of 199show fewer |
|---|
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Imatinib 2 source records aggregated | sensitivity | A | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Dasatinib | sensitivity | A | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Nilotinib | sensitivity | A | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Dasatinib 5 source records aggregated | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 5 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Imatinib Mesylate 3 source records aggregated | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Dasatinib 3 source records aggregated | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Dasatinib 2 source records aggregated | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Ponatinib 2 source records aggregated | sensitivity | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Ponatinib 2 source records aggregated | sensitivity | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G250ESNV → predicts response to Imatinib Mesylate | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Y253HSNV → predicts response to Imatinib Mesylate | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 V299LSNV → predicts response to Imatinib Mesylate | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317VSNV → predicts response to Dasatinib | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | BCL2L11 Deletion Polymorphismdeletion → predicts response to Imatinib | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Imatinib | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Imatinib | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Imatinib Mesylate 33 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 33 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Imatinib 21 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 21 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Dasatinib 11 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 11 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Bosutinib 11 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 11 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Nilotinib 5 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 5 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359VSNV → predicts response to Imatinib Mesylate 3 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Imatinib Mesylate 3 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359CSNV → predicts response to Imatinib Mesylate 3 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Imatinib Mesylate 2 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M244VSNV → predicts response to Imatinib Mesylate 2 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Imatinib Mesylate 2 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M351TSNV → predicts response to Imatinib Mesylate 2 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255VSNV → predicts response to Imatinib Mesylate 2 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 V299LSNV → predicts response to Dasatinib 2 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359VSNV → predicts response to Dasatinib 2 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Bosutinib 2 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G250ESNV → predicts response to Imatinib 2 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359VSNV → predicts response to Imatinib 2 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Y253HSNV → predicts response to Imatinib Mesylate 2 source records aggregated | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Dasatinib 2 source records aggregated | sensitivity | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L364ISNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M244VSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E98GSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 D363GSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E459KSNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L248VSNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E355GSNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 A397PSNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Dasatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 H396RSNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F486SSNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359ISNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Q300RSNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L387FSNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E453ASNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 N336SSNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 C475Vsplice → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Bosutinib | sensitivity | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 D421GSNV → predicts response to Bosutinib | sensitivity | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L387FSNV → predicts response to Bosutinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 V299LSNV → predicts response to Bosutinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L384MSNV → predicts response to Dasatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255VSNV → predicts response to Bosutinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F486SSNV → predicts response to Bosutinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 H396RSNV → predicts response to Bosutinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M351TSNV → predicts response to Dasatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M351TSNV → predicts response to Bosutinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Bosutinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Dasatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Bosutinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G250ESNV → predicts response to Dasatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 P-Loop Mutation → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E459KSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F486SSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G250ESNV → predicts response to Bosutinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 H396RSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 S417YSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L248VSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Y253FSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E355GSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 S438CSNV → predicts response to Dasatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 V379ISNV → predicts response to Imatinib Mesylate | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255VSNV → predicts response to Nilotinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359VSNV → predicts response to Nilotinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359CSNV → predicts response to Nilotinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Nilotinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Y253HSNV → predicts response to Nilotinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 D363GSNV → predicts response to Dasatinib | sensitivity | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Dasatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255VSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Q252HSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Double Ph → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Axitinib | sensitivity | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Axitinib | sensitivity | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M351TSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Imatinib | resistance | C | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Imatinib Mesylate 31 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 31 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Dasatinib 24 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 24 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Nilotinib 23 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 23 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Axitinib 21 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 21 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Imatinib 19 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 19 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Axitinib 6 source records aggregated | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 6 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Nilotinib 6 source records aggregated | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 6 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Nilotinib 5 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 5 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Dasatinib 5 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 5 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Imatinib Mesylate 4 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 4 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Imatinib Mesylate 4 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 4 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Imatinib 4 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 4 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Dasatinib 3 source records aggregated | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| in context · predicts response to | ABL1 V299LSNV → predicts response to Dasatinib 3 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Dasatinib 3 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Imatinib 3 source records aggregated | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Imatinib 3 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Imatinib 3 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Q252HSNV → predicts response to Dasatinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317ISNV → predicts response to Dasatinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Ponatinib 2 source records aggregated | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L248RSNV → predicts response to Axitinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 V299LSNV → predicts response to Axitinib 2 source records aggregated | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Dasatinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G250ESNV → predicts response to Nilotinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317VSNV → predicts response to Dasatinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L248RSNV → predicts response to Imatinib Mesylate 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359CSNV → predicts response to Imatinib Mesylate 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359CSNV → predicts response to Nilotinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Y253HSNV → predicts response to Nilotinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Y253HSNV → predicts response to Imatinib Mesylate 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L248VSNV → predicts response to Imatinib Mesylate 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L248VSNV → predicts response to Nilotinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Nilotinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255VSNV → predicts response to Axitinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Axitinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Q252HSNV → predicts response to Axitinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G250ESNV → predicts response to Axitinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255VSNV → predicts response to Nilotinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 H396RSNV → predicts response to Imatinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M351TSNV → predicts response to Imatinib 2 source records aggregated | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Y253FSNV → predicts response to Imatinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G250ESNV → predicts response to Imatinib 2 source records aggregated | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2 | Curated | civic | graph → |
| in context · predicts response to | LYN OVEREXPRESSIONexpression → predicts response to Nilotinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317SSNV → predicts response to Dasatinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L384MSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L384MSNV → predicts response to Nilotinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Dasatinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Ponatinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 V299LSNV → predicts response to Dasatinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 V299LSNV → predicts response to Ponatinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359ISNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317RSNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E279KSNV → predicts response to Axitinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ASNV → predicts response to Axitinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315VSNV → predicts response to Axitinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 H396RSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 V379ISNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359VSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E355GSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M351TSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317CSNV → predicts response to Dasatinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 D276GSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Q252HSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G250ESNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M244VSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 V299LSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 H396PSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 H396PSNV → predicts response to Nilotinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F311LSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F311LSNV → predicts response to Nilotinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G398RSNV → predicts response to Dasatinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317VSNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M343TSNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F311ISNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 H396RSNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M351TSNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ISNV → predicts response to Axitinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 D276GSNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255KSNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Y253FSNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Y253HSNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L248VSNV → predicts response to Axitinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L387FSNV → predicts response to Nilotinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E292VSNV → predicts response to Nilotinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 E255VSNV → predicts response to Imatinib Mesylate | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 D276GSNV → predicts response to Nilotinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 D276GSNV → predicts response to Imatinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L248VSNV → predicts response to Dasatinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L248VSNV → predicts response to Imatinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359VSNV → predicts response to Imatinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Fusionfusion → predicts response to Bafetinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 L248RSNV → predicts response to Dasatinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 T315ASNV → predicts response to Dasatinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 G398RSNV → predicts response to Nilotinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 V299LSNV → predicts response to Nilotinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F486SSNV → predicts response to Nilotinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 M351TSNV → predicts response to Nilotinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABCB1 Overexpressionexpression → predicts response to Dasatinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABCB1 Overexpressionexpression → predicts response to Bafetinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 Q252HSNV → predicts response to Imatinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F359VSNV → predicts response to Nilotinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | ABL1 F317LSNV → predicts response to Ponatinib | sensitivity | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |
| in context · predicts response to | KIT D816VSNV → predicts response to Imatinib | resistance | D | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Curated | civic | graph → |